Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
Figure 6. NDUFA4L2 expression in normal (n=20) and ccRCC (n=390) specimens.